Lee's Pharmaceutical Holdings Ltd
HKEX:950

Watchlist Manager
Lee's Pharmaceutical Holdings Ltd Logo
Lee's Pharmaceutical Holdings Ltd
HKEX:950
Watchlist
Price: 1.15 HKD -0.86% Market Closed
Updated: May 18, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Lee's Pharmaceutical Holdings Ltd

Wall Street analysts forecast Lee's Pharmaceutical Holdings Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Lee's Pharmaceutical Holdings Ltd is 1.02 HKD with a low forecast of 1.01 HKD and a high forecast of 1.05 HKD.

Lowest Forecast
Wall Street Target
1.01 HKD
12% Downside
Average Forecast
Wall Street Target
1.02 HKD
11% Downside
Highest Forecast
Wall Street Target
1.05 HKD
9% Downside
Lowest
Price Target
1.01 HKD
12% Downside
Average
Price Target
1.02 HKD
11% Downside
Highest
Price Target
1.05 HKD
9% Downside
Lee's Pharmaceutical Holdings Ltd Competitors:
Price Targets
1760
Panion & BF Biotech Inc
12% Upside
M
MANKIND
Mankind Pharma Ltd
1% Upside
T
600488
Tianjin Tianyao Pharmaceuticals Co Ltd
37% Upside
G
002424
Guizhou Bailing Group Pharmaceutical Co Ltd
370% Upside
1760
Panion & BF Biotech Inc
12% Upside
M
MANKIND
Mankind Pharma Ltd
1% Upside
T
600488
Tianjin Tianyao Pharmaceuticals Co Ltd
37% Upside
G
002424
Guizhou Bailing Group Pharmaceutical Co Ltd
370% Upside
COLL
Collegium Pharmaceutical Inc
26% Upside
C
1093
CSPC Pharmaceutical Group Ltd
47% Upside
PBH
Prestige Consumer Healthcare Inc
19% Upside
J
000919
Jinling Pharmaceutical Co Ltd
26% Upside

Revenue
Forecast

Revenue Estimate
Lee's Pharmaceutical Holdings Ltd

For the last 8 years the compound annual growth rate for Lee's Pharmaceutical Holdings Ltd's revenue is 2%. The projected CAGR for the next 2 years is 18%.

2%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Lee's Pharmaceutical Holdings Ltd

For the last 8 years the compound annual growth rate for Lee's Pharmaceutical Holdings Ltd's operating income is -21%. The projected CAGR for the next 2 years is 70%.

-21%
Past Growth
70%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Lee's Pharmaceutical Holdings Ltd

For the last 8 years the compound annual growth rate for Lee's Pharmaceutical Holdings Ltd's net income is -28%. The projected CAGR for the next 2 years is 124%.

-28%
Past Growth
124%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Lee's Pharmaceutical Holdings Ltd's stock price target?
Price Target
1.02 HKD

According to Wall Street analysts, the average 1-year price target for Lee's Pharmaceutical Holdings Ltd is 1.02 HKD with a low forecast of 1.01 HKD and a high forecast of 1.05 HKD.

What is Lee's Pharmaceutical Holdings Ltd's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Lee's Pharmaceutical Holdings Ltd's revenue is 2%. The projected CAGR for the next 2 years is 18%.

What is Lee's Pharmaceutical Holdings Ltd's Operating Income forecast?
Projected CAGR
70%

For the last 8 years the compound annual growth rate for Lee's Pharmaceutical Holdings Ltd's operating income is -21%. The projected CAGR for the next 2 years is 70%.

What is Lee's Pharmaceutical Holdings Ltd's Net Income forecast?
Projected CAGR
124%

For the last 8 years the compound annual growth rate for Lee's Pharmaceutical Holdings Ltd's net income is -28%. The projected CAGR for the next 2 years is 124%.

ALPHA SPREAD
Join more than 138,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.